P1532: SUTIMLIMAB AFTER PRIOR RITUXIMAB USE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): POOLED POST-HOC ANALYSES FROM THE CARDINAL AND CADENZA TRIALS

• A. Röth,
• A. Karaouni,
• J. Msihid,
• I. Hemim,
• F. Joly,
• F. Shafer,
• T. Sourdille,
• Q. Hill

Affiliations

A. Röth

1 Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany

A. Karaouni

2 BMAPS SARL, Geneva, Switzerland

J. Msihid

3 Sanofi, Chilly-Mazarin, France

I. Hemim

3 Sanofi, Chilly-Mazarin, France

F. Joly

3 Sanofi, Chilly-Mazarin, France

F. Shafer

4 Sanofi, Bridgewater

T. Sourdille

5 Sanofi, New York, United States of America

Q. Hill

6 Department of Clinical Hematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom